Reshma Kewalramani

Biography

Reshma Kewalramani, M.D., FASN, joined Vertex in 2017 as Senior Vice President, Late Development. In this role, Dr. Kewalramani leads the Cystic Fibrosis and General Medicine Clinical Development therapeutic areas, Clinical Development Execution, Medical Writing and Medical Affairs. Prior to Vertex, Dr. Kewalramani spent more than 12 years at Amgen where she held a variety of roles across Research and Development, including as Vice President Global Clinical Development, Nephrology & Metabolic Therapeutic Area and Vice President, US Medical Organization, a group she established and grew to assume responsibility for the full portfolio of molecules across six therapeutic areas. 

Research Interest

Pediatric Care, Pediatric Neurology, Pediatric Cardiology, Pediatric & Neonatal Medicine